查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1928280

生物来源Isododecane市场依原料类型、纯度等级、应用、最终用户和销售管道－全球预测，2026-2032年

Bio-based Isododecane Market by Feedstock Type, Purity Grade, Application, End User, Sales Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年生物基异Isododecane市值为 1.7529 亿美元，预计到 2026 年将成长至 2.1072 亿美元，年复合成长率为 22.38%，到 2032 年将达到 7.2104 亿美元。

关键市场统计数据
基准年 2025 1.7529亿美元
预计年份：2026年 2.1072亿美元
预测年份 2032 7.2104亿美元
复合年增长率 (%) 22.38%

策略性实施方案，将生物基异Isododecane的物理化学优势与配方优先顺序、供应考量和监管考虑因素结合。

生物基异Isododecane作为一种用途广泛、气味低、快干的碳氢化合物替代品，已在配方驱动型产业中广受欢迎。随着配方化学家和采购团队寻求更优质的原料供应和永续性，生物基异Isododecane因其与敏感化妆品基质、吸入产品溶剂系统、润滑剂基底和工业清洁配方的相容性而日益受到重视。其理化性质使其在对挥发性控制、肤感和溶剂纯度要求极高的领域极具吸引力。

原料创新、认证要求和纯化技术突破所驱动的变革性产业趋势正在重塑生物基异Isododecane的应用路径。

受永续性需求、发酵和催化製程的成熟以及原料供应变化等因素的影响，生物基异Isododecane的市场环境正在经历结构性变革。可再生原料加工技术的创新正逐步改善杂质谱和可重复性，从而促进其在敏感应用领域的更广泛应用。同时，买家越来越重视透明度和第三方认证，以支持其永续性声明，这正在推动供应商选择标准和合约条款的调整。

对2025年美国关税调整对筹资策略、供应链结构和海关风险管理实务的影响进行全面分析

2025年的关税环境为美国跨境供应链增添了新的复杂性，影响了采购决策和合约风险分配。关税调整影响了到岸成本的计算，迫使采购团队重新评估其供应商分布、运输策略和库存管理政策。为此，一些买家转向区域采购以最大限度地降低跨境关税波动风险，而另一些买家则重新谈判供应合同，以纳入关税分摊条款和弹性价格设定机制。

详细的細項分析揭示了应用特定要求、纯度差异、最终用户优先事项、分销管道趋势和原材料选择如何决定认证和采购。

细分市场分析揭示了不同应用、纯度等级、最终用户、销售管道和原材料类型所带来的独特需求驱动因素和合格路径。该材料的价值提案在不同应用领域差异显着：在化妆品领域，它可用作粉底、唇膏和保湿霜配方中的感官增强剂，这些产品对肤感和速干性要求较高；在工业溶剂领域，其速干、低残留的溶剂特性适用于清洁剂和涂料；在润滑剂领域，它可用作生物润滑剂和特殊金属加工液的生物基基础材料，这些产品对热稳定性和成膜性能要求较高；在製药领域，它可用作吸入剂或外用溶剂，这些产品对溶剂纯度和与活性成分的相容性要求较高。

区域趋势和生产布局影响美洲、欧洲、中东和非洲以及亚太地区的供应韧性、认证重点和物流优化。

生物基异Isododecane的地理趋势取决于区域原料供应、法规结构和製造地。在美洲，由于地理位置接近性玉米和醣类原料产地，有利于本地生产和缩短供应链，而可追溯性和本土采购是买家优先考虑的因素。同时，在欧洲、中东和非洲地区，监管审查和永续性报告要求促使企业更加重视认证采购和生命週期透明度，製造商通常会投资于先进的提纯技术，以满足化妆品和药品行业的严格标准。

关键竞争考察和能力洞察，重点在于阐述技术差异化、材料整合和附加价值服务如何决定供应商定位和客户选择。

生物基异Isododecane领域的竞争趋势主要集中在技术差异化、原料整合、垂直整合和附加价值服务。领先的生产商通常将原料采购伙伴关係关係与下游提纯能力和完善的品管系统相结合，以满足高纯度应用的需求。新参与企业和特种化学品製造商则往往透过提供灵活的合约规模、为配方师提供快速的中试支援以及基于第三方检验的新型原料特性来展开竞争。

为确保供应韧性、提升纯度能力以及使商业模式与永续性和监管要求相符，提出切实可行的策略建议。

产业领导者应优先采取一系列切实可行的措施，将不确定性转化为竞争优势。首先，透过多元化采购管道，选用相容的原料类型，并建立能够适应关税和供应波动的条件性采购协议，加强原物料风险管理。其次，在不影响合规性的前提下，透过投资满足化妆品和药品应用最高纯度要求的纯化和分析能力，扩大潜在需求。

我们采用严谨的混合方法研究途径，结合专家访谈、技术检验、供应链分析和法规分析，为我们的商业性建议奠定基础。

本调查方法融合了深度访谈、针对性技术检验和全面的二手资讯分析，以建立坚实的证据基础。深度研究包括对来自终端用户领域的高级采购、配方和法规专业人员进行结构化访谈，以了解他们的决策标准、资格认证经验以及对政策变化的采购应对措施。此外，还透过与分析化学家和製程工程师的技术交流，对这些定性资料进行三角验证，以检验杂质谱、纯化限制和放大生产方面的考量。

简洁扼要的结论将技术、商业性和监管要求整合为跨部门的必要条件，以实现生物基异Isododecane的成功应用。

本研究的整体结果表明，生物基异Isododecane正从一种小众替代品转变为一种重要的基础原料，这需要严格的技术合格、稳健的供应策略以及透明的永续性声明。采用者必须权衡产品性能与采购实际情况，尤其是在关税制度和原材料供应情况为到岸成本和供应连续性计算引入新变数的情况下。对于配方团队而言，关键问题仍然是感官相容性、杂质控制和法规可追溯性。对于采购和供应链经理而言，管理关税风险、物流复杂性和原料季节性波动仍是首要任务。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章生物来源Isododecane市场（按原始类型划分）

  • 玉米
  • 棕榈
  • 甘蔗

第九章生物来源Isododecane市场（依纯度等级划分）

  • 化妆品级
  • 工业级
  • 医药级

第十章生物来源Isododecane市场（依应用领域划分）

  • 化妆品
    • 基础
    • 口红
    • 保湿霜
  • 工业溶剂
    • 打扫
    • 涂层
  • 润滑油
    • 生物润滑剂
    • 金属加工油
  • 製药
    • 吸入溶剂
    • 外用溶剂

第十一章生物来源Isododecane市场（以最终用户划分）

  • 工业的
  • 个人护理
  • 製药

第十二章生物来源Isododecane市场（依销售管道划分）

  • 直销
  • 批发商
  • 在线的

第十三章生物来源Isododecane市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章生物来源Isododecane市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国生物来源Isododecane市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

16. 美国生物来源Isododecane市场

第十七章 中国生物来源Isododecane市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Arkema SA
  • BASF SE
  • Clariant AG
  • Croda International Plc
  • Dow Inc.
  • Evonik Industries AG
  • Haltermann Carless
  • Inolex Chemical Company
  • Koster Keunen, Inc.
  • Solvay SA
  • Symrise AG
Product Code: MRR-92740D85EF14

The Bio-based Isododecane Market was valued at USD 175.29 million in 2025 and is projected to grow to USD 210.72 million in 2026, with a CAGR of 22.38%, reaching USD 721.04 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 175.29 million
Estimated Year [2026] USD 210.72 million
Forecast Year [2032] USD 721.04 million
CAGR (%) 22.38%

A strategic introduction that connects bio-based isododecane's physicochemical advantages to formulation priorities, supply considerations, and regulatory sensitivities

Bio-based isododecane has emerged as a versatile, low-odor, and fast-evaporating hydrocarbon alternative prized across formulation-centric industries. As formulation chemists and procurement teams seek feedstock resilience and improved sustainability credentials, bio-based isododecane is increasingly evaluated for its compatibility with sensitive cosmetic matrices, solvent systems for inhalation products, lubricant backbones, and industrial cleaning formulations. Its physicochemical properties make it attractive where volatility control, skin feel, and solvent purity are critical.

This section frames the product's relevance by connecting material attributes to end-user priorities. For cosmetic formulators, sensory performance and regulatory acceptability dominate decisions, while industrial purchasers emphasize supply continuity and cost-of-goods dynamics. In the pharmaceutical arena, solvent purity and regulatory traceability are paramount. Across these contexts, bio-based feedstocks introduce additional considerations around lifecycle impacts, trace impurities, and certification pathways. The introduction establishes the scope of inquiry by linking technical characteristics to commercial decision drivers, setting the stage for a deeper look at market shifts, segmentation nuances, regional dynamics, and actionable guidance for stakeholders.

Transformative industry dynamics driven by feedstock innovation, certification demands, and purification breakthroughs reshaping adoption pathways for bio-based isododecane

The landscape for bio-based isododecane is undergoing structural shifts driven by sustainability imperatives, technological maturation in fermentation and catalytic pathways, and changes in feedstock availability. Innovation in renewable feedstock processing is gradually improving impurity profiles and reproducibility, enabling wider acceptance in sensitive applications. At the same time, buyers are placing greater emphasis on transparency and third-party certification to substantiate sustainability claims, which reshapes supplier selection criteria and contractual terms.

Concurrently, advancements in downstream purification and analytical methods have reduced barriers to entry for pharmaceutical and high-purity cosmetic applications that previously relied on petrochemical analogues. These technological improvements have been accompanied by evolving procurement strategies: formulators are diversifying supplier bases, integrating longer-term offtake agreements, and structuring quality agreements to mitigate variability. Regulatory scrutiny around bio-based claims and feedstock sourcing is increasing, prompting manufacturers to formalize chain-of-custody documentation and lifecycle accounting. Taken together, these shifts are transitioning the market from early-adopter experimentation toward a more institutionalized procurement and qualification framework.

Comprehensive analysis of how 2025 United States tariff adjustments have reshaped sourcing strategies, supply chain architecture, and customs risk management practices

The tariff environment instituted in 2025 has introduced new layers of complexity for supply chains that cross the United States border, affecting sourcing decisions and contractual risk allocation. Tariff adjustments have influenced landed cost calculations, prompting procurement teams to reassess supplier geographies, freight strategies, and inventory policies. In response, some buyers have shifted to regional sourcing to minimize exposure to cross-border tariff volatility, while others have renegotiated supply agreements to include tariff-sharing clauses or flexible pricing mechanisms tied to customs duties.

Tariff effects have also accelerated attention on local content and domestic production capabilities, incentivizing investments in regional feedstock processing and downstream purification facilities. These investments aim to reduce dependency on long-haul imports and to provide greater control over quality and compliance. Meanwhile, logistics planners have responded by redesigning inventory buffers and by exploring bonded warehousing solutions to manage duty timing. From a regulatory standpoint, tariff changes have increased the value of precise HS code classification and customs expertise, as misclassification risks can lead to unexpected financial exposure. Overall, the cumulative tariff impact has elevated strategic sourcing and customs management to boardroom-level considerations for organizations that rely on bio-based isododecane.

In-depth segmentation insight revealing how application-specific requirements, purity distinctions, end-user priorities, channel dynamics, and feedstock choices dictate qualification and procurement

Segmentation analysis reveals distinct demand drivers and qualification pathways across application, purity grade, end user, sales channel, and feedstock type. Based on Application, the material's value proposition differs markedly: in Cosmetics it functions as a sensory enhancer across Foundation, Lipstick, and Moisturizer formulations where skin feel and rapid drydown are critical; in Industrial Solvents it supports Cleaning and Coatings with solvency profiles that favor rapid evaporation and low residue; in Lubricants it serves as a bio-derived base for Bio-Lubricants and specialized Metalworking Fluids where thermal stability and film properties matter; and in Pharmaceuticals it acts as an Inhalation Solvent and Topical Solvent where solvent purity and compatibility with active ingredients are non-negotiable.

Based on Purity Grade, qualification pathways diverge considerably: Cosmetic Grade materials require sensory and dermatological acceptability evidence, Industrial Grade emphasizes process consistency and impurity tolerance, and Pharmaceutical Grade demands rigorous analytical traceability and compliance with pharmacopeial or regulatory requirements. Based on End User, the purchasing lens shifts from industrial buyers focused on operational uptime and cost-per-liter to personal care formulators prioritizing regulatory alignment and sensory differentiation and to pharma customers focused on validated supply chains and controlled impurity profiles. Based on Sales Channel, procurement behaviors vary between Direct relationships that enable technical collaboration, Distributor arrangements that offer logistical reach and inventory buffering, and Online channels that cater to smaller-volume or rapid-prototyping purchases. Based on Feedstock Type, supply risk and sustainability narratives differ across Corn, Palm, and Sugarcane, each bringing distinct land-use implications, supply seasonality, and certification pathways. Understanding the interplay among these segmentation axes is essential for positioning product specifications, packaging offers, and commercial terms to meet the nuanced expectations of each buyer cohort.

Regional dynamics and production footprints shaping supply resilience, certification priorities, and logistics optimization across the Americas, Europe, Middle East & Africa, and Asia-Pacific

Geographic dynamics for bio-based isododecane reflect regional feedstock availability, regulatory frameworks, and manufacturing footprint considerations. In the Americas, proximity to corn and sugar-derived feedstocks supports localized production and shorter supply chains, with buyers emphasizing traceability and domestic sourcing as priorities. Meanwhile, in Europe, Middle East & Africa, regulatory scrutiny and sustainability reporting requirements create a premium on certified feedstock sourcing and lifecycle transparency, and manufacturers often invest in advanced purification to meet stringent cosmetic and pharmaceutical standards.

In the Asia-Pacific region, diverse feedstock ecosystems and a broad manufacturing base support a wide array of production pathways, from palm-based processes to sugarcane-derived routes. Regional logistics hubs in this geography facilitate exports to adjacent markets, but stakeholders must navigate a patchwork of local regulations and certification regimes. Across all regions, cross-border trade patterns are influenced by feedstock seasonality, currency volatility, and evolving environmental policy. Strategic regional approaches therefore combine local production where feasible with flexible logistics and quality assurance frameworks to ensure consistent product performance and compliance for global customers.

Key competitive and capability insights highlighting how technical differentiation, feedstock integration, and value-added services determine supplier positioning and customer choice

Competitive dynamics in bio-based isododecane center on technical differentiation, feedstock integration, vertical coordination, and value-added services. Leading producers typically combine feedstock sourcing partnerships with downstream purification capabilities and robust quality management systems to meet the demands of high-purity applications. New entrants and specialty chemical firms often compete by offering flexible contract sizes, rapid prototyping support for formulators, or novel feedstock claims backed by third-party validation.

Service providers and toll manufacturers play a critical role in enabling scale-up and in mitigating capital intensity for companies seeking to enter the space. Technical service offerings-such as application trials, analytical method development, and co-development programs-broaden commercial appeal and reduce qualification friction for buyers. Strategic collaborations between suppliers and end users are increasingly common, with joint development agreements used to accelerate product compatibility testing and to secure offtake commitments. Ultimately, the competitive landscape rewards organizations that can marry technical excellence with supply assurance and transparent sustainability narratives.

Actionable strategic recommendations to secure supply resilience, enhance purity capabilities, and align commercial models with sustainability and regulatory requirements

Industry leaders should prioritize a set of pragmatic actions to convert uncertainty into competitive advantage. First, strengthen feedstock risk management by diversifying procurement across compatible feedstock types and by establishing conditional sourcing agreements that can be activated in response to tariff or supply volatility. Second, invest in purification and analytical capacity to meet the highest purity expectations for cosmetic and pharmaceutical applications, thereby expanding addressable demand without compromising compliance.

Third, formalize sustainability and chain-of-custody reporting to support customer claims and to facilitate participation in major corporate procurement programs. Fourth, develop flexible commercial structures such as tiered pricing or shared-tariff mechanisms to mitigate the impact of trade policy shifts for key customers. Fifth, expand technical support offerings, including in-application testing and co-development partnerships, to reduce buyer qualification lead times. Finally, pursue regional manufacturing or tolling partnerships where logistics and tariff exposure materially affect supply cost and reliability. By sequencing these initiatives-prioritizing quality and regulatory readiness while progressively de-risking feedstock and trade exposures-industry leaders can position themselves to capture emerging demand driven by sustainability and formulation innovation.

Rigorous mixed-methods research approach combining expert interviews, technical validation, supply chain mapping, and regulatory analysis to underpin commercial recommendations

The research methodology blends primary interviews, targeted technical validation, and comprehensive secondary intelligence to create a robust evidence base. Primary research included structured interviews with senior procurement, formulation, and regulatory professionals across end-user segments to capture decision criteria, qualification experiences, and procurement responses to policy shifts. These qualitative inputs were triangulated with technical conversations involving analytical chemists and process engineers to validate impurity profiles, purification constraints, and scale-up considerations.

Secondary research encompassed review of regulatory guidance, certification frameworks, and publicly available technical literature on bio-based hydrocarbon production pathways. Supply chain mapping integrated customs data, logistics patterns, and feedstock seasonality to construct plausible sourcing scenarios, while scenario planning exercises were used to stress-test sourcing strategies against tariff and feedstock disruption cases. Throughout the study, findings were validated through iterative peer review and by reconciling technical laboratory summaries with buyer expectations to ensure that commercial recommendations are grounded in practical qualification realities.

A concise conclusion that synthesizes technical, commercial, and regulatory imperatives into a cross-functional imperative for reliable adoption of bio-based isododecane

The cumulative narrative of this study emphasizes that bio-based isododecane is shifting from a niche alternative toward a component that requires disciplined technical qualification, robust supply strategies, and transparent sustainability claims. Adopters must balance product performance against procurement realities, particularly as tariff regimes and feedstock availability inject new variables into landed cost and supply continuity calculations. For formulation teams, the chief concerns remain sensory compatibility, impurity control, and regulatory traceability; for procurement and supply chain leaders, managing tariff exposure, logistics complexity, and feedstock seasonality is paramount.

Success in this environment depends on aligning technical capabilities with commercial flexibility. Organizations that invest in purification and analytical capacity, formalize certification and chain-of-custody practices, and adopt creative contractual mechanisms to share trade policy risk will be better positioned to deliver consistent product performance to their customers. The conclusion synthesizes these themes into a straightforward imperative: treat bio-based isododecane qualification as a cross-functional initiative that bridges R&D, procurement, and regulatory affairs to convert material attributes into reliable commercial outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Bio-based Isododecane Market, by Feedstock Type

  • 8.1. Corn
  • 8.2. Palm
  • 8.3. Sugarcane

9. Bio-based Isododecane Market, by Purity Grade

  • 9.1. Cosmetic Grade
  • 9.2. Industrial Grade
  • 9.3. Pharmaceutical Grade

10. Bio-based Isododecane Market, by Application

  • 10.1. Cosmetics
    • 10.1.1. Foundation
    • 10.1.2. Lipstick
    • 10.1.3. Moisturizer
  • 10.2. Industrial Solvents
    • 10.2.1. Cleaning
    • 10.2.2. Coatings
  • 10.3. Lubricants
    • 10.3.1. Bio-Lubricants
    • 10.3.2. Metalworking Fluids
  • 10.4. Pharmaceuticals
    • 10.4.1. Inhalation Solvents
    • 10.4.2. Topical Solvents

11. Bio-based Isododecane Market, by End User

  • 11.1. Industrial
  • 11.2. Personal Care
  • 11.3. Pharma

12. Bio-based Isododecane Market, by Sales Channel

  • 12.1. Direct
  • 12.2. Distributor
  • 12.3. Online

13. Bio-based Isododecane Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Bio-based Isododecane Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Bio-based Isododecane Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Bio-based Isododecane Market

17. China Bio-based Isododecane Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Arkema S.A.
  • 18.6. BASF SE
  • 18.7. Clariant AG
  • 18.8. Croda International Plc
  • 18.9. Dow Inc.
  • 18.10. Evonik Industries AG
  • 18.11. Haltermann Carless
  • 18.12. Inolex Chemical Company
  • 18.13. Koster Keunen, Inc.
  • 18.14. Solvay S.A.
  • 18.15. Symrise AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIO-BASED ISODODECANE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BIO-BASED ISODODECANE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES BIO-BASED ISODODECANE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA BIO-BASED ISODODECANE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY CORN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY CORN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY CORN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PALM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PALM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PALM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY SUGARCANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY SUGARCANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY SUGARCANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY COSMETIC GRADE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY COSMETIC GRADE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY COSMETIC GRADE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL GRADE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL GRADE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL GRADE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICAL GRADE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICAL GRADE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICAL GRADE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY FOUNDATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY FOUNDATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY FOUNDATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY LIPSTICK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY LIPSTICK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY LIPSTICK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY MOISTURIZER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY MOISTURIZER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY MOISTURIZER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY CLEANING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY CLEANING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY CLEANING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY COATINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY COATINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY COATINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY BIO-LUBRICANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY BIO-LUBRICANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY BIO-LUBRICANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY METALWORKING FLUIDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY METALWORKING FLUIDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY METALWORKING FLUIDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY INHALATION SOLVENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY INHALATION SOLVENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY INHALATION SOLVENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY TOPICAL SOLVENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY TOPICAL SOLVENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY TOPICAL SOLVENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PERSONAL CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PERSONAL CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PERSONAL CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PHARMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PHARMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PHARMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY DIRECT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY DIRECT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY DIRECT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY DISTRIBUTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY DISTRIBUTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS BIO-BASED ISODODECANE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA BIO-BASED ISODODECANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA BIO-BASED ISODODECANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE BIO-BASED ISODODECANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST BIO-BASED ISODODECANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC BIO-BASED ISODODECANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN BIO-BASED ISODODECANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 178. GCC BIO-BASED ISODODECANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. GCC BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. GCC BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 181. GCC BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 182. GCC BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 183. GCC BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2032 (USD MILLION)
  • TABLE 184. GCC BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2032 (USD MILLION)
  • TABLE 185. GCC BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 186. GCC BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. GCC BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION BIO-BASED ISODODECANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS BIO-BASED ISODODECANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 208. G7 BIO-BASED ISODODECANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 209. G7 BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. G7 BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 211. G7 BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. G7 BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 213. G7 BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2032 (USD MILLION)
  • TABLE 214. G7 BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2032 (USD MILLION)
  • TABLE 215. G7 BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 216. G7 BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 217. G7 BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 218. NATO BIO-BASED ISODODECANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 219. NATO BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. NATO BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 221. NATO BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. NATO BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 223. NATO BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2032 (USD MILLION)
  • TABLE 224. NATO BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2032 (USD MILLION)
  • TABLE 225. NATO BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 226. NATO BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 227. NATO BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 228. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES BIO-BASED ISODODECANE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 233. UNITED STATES BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 234. UNITED STATES BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 239. CHINA BIO-BASED ISODODECANE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 240. CHINA BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. CHINA BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 243. CHINA BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 244. CHINA BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2032 (USD MILLION)
  • TABLE 245. CHINA BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2032 (USD MILLION)
  • TABLE 246. CHINA BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 247. CHINA BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)